Transdermal delivery of peptide and protein drugs: An overview

AIChE Journal

Volumn 41, Issue 8, 1995, Pages 1972-1997

  Amsden, B G ^a   Goosen, M F A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; MASS TRANSFER; PROTEINS; SKIN; ULTRASONICS;

ELECTROPORATION; IONTOPHORESIS; PEPTIDE; TRANSDERMAL DRUG DELIVERY;

CONTROLLED DRUG DELIVERY;

EID: 0029357156     PISSN: 00011541     EISSN: 15475905     Source Type: Journal    
DOI: 10.1002/aic.690410814     Document Type: Review

References (181)

1. Skin Reactions X: Pre‐seasonal Treatment of Hay Fever by Electrophoresis of Ragweed Pollen Extracts into the Skin. Preliminary Report
2. Percutaneous Absorption: 'Theoretical Description
3. Effect of Pre‐heating on the Permeability of Neonatal Rat Stratum Corneum to Alkanols
4. A Generic Protein Delivery System Based on Osmotically Rupturable Monoliths
5. Variations in Physical Dimensions and Chemical Composition of Human Stratum Corneuni
6. A Comparison of Pulsed and Continuous Current lontophoresis
7. Controlled Release: Mechanisms and Rates
8. Transdermal Permeation of Vasopressin: J. Influence of pH, Concentration, Shaving and Surfactant on in vitro Permeation
9. Hydrogel‐Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs
10. The Transdermal Route for the Delivery of Peptides and Proteins
11. Enhanced Percutaneous Absorption via lontophoresis I. Evaluation of an in vitro System and Transport of Model Compounds
12. Use of Ultrasound to Enhance Percutaneous Penetration of Benzydamine
13. Pharmacokinetics of Transdermal Drug Delivery
14. Models of Skin Permeability
15. Anatomy and Biochemistry of the Skin
16. The Diffusion of Water Across the Stratum Corneum as a Function of Its Water Content
17. Transdermal Peptide Delivery
18. 2 Transport through Human Skin in vitro
19. Visualization of in vitro Percutaneous Penetration of Mercuric Chloride; Transport through Intercellular Space versus Cellular Uptake through Desmosomes
20. Sonophoresis: I. The Use of High‐Frequency Ultrasound to Enhance Transdermal Drug Delivery
21. Sonophoresis: II. Examination of the Mechanism(s) of Ultrasound‐Enhanced Transdermal Drug Delivery
22. Thermodynamic and Structural Aspects of the Skin Barrier
23. The Utility of the Prodrug Approach to Improve Peptide Absorption
24. lontophoresis
25. Comparison Between the Iontophoretic and Passive Transport of Thyrotropin Releasing Hormone across Excised Nude Mouse Skin
26. Characterization of the Pore Transport Properties and Tissue Alteration of Excised Human Skin during lontophoresis
27. Characterization of the Permselective Properties of Excised Human Skin during Iontophoresis
28. Transfer of Monoclonal Antibodies into Mammalian Cells by Electroporation
29. Effect of Dimethyl Sulfoxide on Drug Permeation Through Human Skin
30. Pharmacokinetics of Drug Permeation Through Human Skin
31. Application of the 'Dual Sorption' Model to Drug Transport Through Skin
32. Overview of Electroporation and Electrofusion
33. Structure and Dynamics of Electric Field‐Induced Membrane Pores as Revealed by Rapid‐Freezing Electron Microscopy
34. Electropores in Lipid Lamellacs and Cell Membranes
35. Facilitated Transdermal Delivery of Therapeutic Peptides and Proteins by lontophoretic Delivery Devices
36. Direct Current lontophoretic Transdermal Delivery of Peptide and Protein Drugs
37. Transdermal Delivery of Bioactive Peptides: The Effect of n‐Decyl Methyl Sulfoxide, pH, and Inhibitors on Enkaphalin Metabolism and Transport
38. Studies of the Penetration of Native Collagen, Collagen Alpha Chains, and Collagen Cyanogen Bromide Peptides Through Hairless Mouse Skin in vitro
39. Molecular Transport in Liquids and Gases
40. Increased Skin Permeability for Lipophilic Molecules
41. Penetration Enhancers
42. Evaluation of a Pulsed Current and High‐Frequency Voltage Sampling System Designed to Study Transdermal Peptide lontophoresis and Skin Impedance
43. Site of Jontophoretic Current Flow into the Skin: Identification and Characterization with the Vibrating Probe Electrode
44. What Are the Pathways of Lontophoretic Current Flow Through Mammalian Skin?
45. Effect of Skin Binding on Percutaneous Transport of Benzocaine from Aqueous Suspensions and Solutions
46. In vitro Transdermal Delivery of a Melanotropic Peptide through Human Skin
47. Hindered Transport of Large Molecules in Liquid‐Filled Pores
48. Characterization of Convective Solvent Flow during lontophoresis
49. Evaluation of the Nude Rat as a Model: Effects of Short‐Term Freezing and Alkyl Chain Length on the Permeabilities of n‐Alkanols and Water
50. Controlled‐Release Delivery Advances Bode Well for Biopharmaceutical Manufacturers
51. The Microscopic Structure of the Epidermis and Its Derivatives
52. Epidermal Lipids, Membranes, and Keratinization
53. The Mammalian Cutaneous Permeability Barrier: Defective Function in Essential Fatty Acid Deficiency Correlates with Abnormal Intercellular Lipid Deposition
54. Percutaneous Transport in Relation to Stratum Corneum Structure and Lipid Composition
55. The Permeability Barrier in Mammalian Epidermis
56. The Isolation of Dimethyl Sulfoxide Soluble Components from Human Epidermal Preparations: A Possible Mechanism of Action of Dimethyl Sulfoxide in Effecting Perutaneous Migration Phenomena
57. Mechanism of Percutaneous Absorption from Physicochemical Evidence
58. Parameters of Skin Condition and Function
59. Increased Penetration of Nonelectrolytes into Mouse Skin During Iontophoretic Water Transport
60. Role of Stratum Corneum Lipid Fluidity in Transdermal Drug Flux
61. Action of Penetration Enhancers on Human Stratum Comeum as Assessed by Differential Scanning Calorimetiy
62. Differential Scanning Calorimetry (DSC) of Human Stratum Corneum: Effect of Azone
63. Isolation and Lipid Biochemical Characterization of Stratum Coreum Membrane Complexes: Implications for the Cutaneous Permeability Barrier
64. Lontophoretic Delivery of a Series of Tripeptides Across the Skin in vitro
65. In vitro and in vivo lontophoresis of a Tripeptide Across Nude Rate Skin
66. Transdermal lontophoresis of Amino Acids and Peptides in vitro
67. Pathways of Ionic Flow Through Human Skin in vivo
68. The Prediction of Plasma Levels of Drugs Following Transdermal Application
69. Drug Parameters Important for Transdermal Delivery
70. Penetration Enhancers in Percutaneous Absorption
71. Introduction of Phalloidin Labelled with Fluorescein Isothiocyanate into Living Polymorphonuclear Leukocytes by Electroporation
72. Transdermal lontophoretic Delivery:in vitro and in vivo Studies with Lutenizing Hormone Releasing Hormone
73. Prodrugs in Transdermal Delivery
74. Transdermal Penetration Enhancers in Rabbit Pinna Skin: Duration of Action, Skin Irritation and in vivo/in vitro Comparisons
75. Transdermal Lontophoresis of Sotalol and Salicylate; The Effect of Skin Charge and Penetration Enhancers
76. Kinetics, Ultrastructural Aspects and Molecular Modelling of Transdermal Peptide Flux Enhancement by N‐Alkylazacycloheptanones
77. Lontophoretic Enhancement of Peptides: Behaviour of Leuprolide versus Model Permeants
78. The Percutaneous Absortion of Some Anionic Surfac Anionic Surfactants
79. Transfollicular Percutaneous Absorption ‐Skin Model for Quantitative Studies
80. Follicles Play an Important Role in Percutaneous Absorption
81. Modifications Induced on Stratum Corneum Structure After lontophoresis: ATRFTIR and X‐Ray Diffraction Studies
82. Control of Glucose Levels in Alloxan‐Diabetic Rabbits by lontophoresis of Insulin
83. Topical Absorption of Polypeptides with Dimenthylsulfoxide
84. Effect of Lipid Solubility and Molecular Size on Percutaneous Absorption
85. The Use of Transient Diffusion to Investigate Transport Pathways Through the Skin
86. Topical Pharmacology and Toxicology of Dimethyl Sulfoxide: I
87. Ultrasound Induced Delivery of Peptides
88. A Compartment Model for Percutaneous Drug Absorption
89. Effect of lonotophoresis on in vitro Skin Permeation of an Analogue of Growth Hormone Releasing Factor in the Hairless Pig Model
90. Physicochemical Study of Percutaneous Absorption by Dimethyl Sulfoxide: Kinetic and Thermodynamic Determinants of Dimethyl Sulfoxide Mediated Mass Transfer of Alkanols
91. Human Stratum Corneum Lipids: Characterization and Regional Variations
92. Bicavailability of Macromolecular Drugs and Its Control
93. Topical Administration of Penetration Enhancers to the Skin of Nude Mice: A Histological Study
94. Peptide and Protein Drug Delivery Systems
95. Transdermal lontophoretic Delivery of Arginine‐Vasopressin (I): Physicochemical Considerations
96. Effect of Ultrasound on Transdermal Drug Delivery to Rats and Guinea Pigs
97. Delivery of Recombinant Peptide and Protein Drugs
98. Pharmacokinetic and Pharmacodynamic Aspects of Polypeptide Delivery
99. Successful Transdermal Administration of Therapeutic Doses of a Polypeptide to Normal Human Volunteers
100. Transdermal versus Subcutaneous Leuprolide: A Comparison of Acute Pharmacodynamic Effect
101. Drug Permeation though Human Skin: Theory and in vitro Experimental Measurement
102. Transdermal lontophoresis of Gonadotropin Releasing Hormone (LHRH) and Two Analogues
103. External Control of Drug Release and Penetration: Enhancement of the Transdermal Absorption of Indomethacin by Ultrasound Irradiation
104. Identification of the Pathway of lontophoretic Delivery: Light and Ultra‐structural Studies Using Mercuric Chloride, in Pigs
105. Prodrugs of Peptides. 7. Transdermal Delivery of Thyrotropin Releasing Hormone (TRH) via Prodrugs
106. Cutaneous Metabolism of Xenobiotics
107. Inflammatory Response to Sodium Lauryl Sulfate in Aqueous Solutions Applied to the Skin of Normal Human Volunteers
108. New Iontophoretic Transdermal Administration of the Beta‐Blocker Metropropol
109. Skin Permeability of Water‐Soluble Drugs
110. The Skin as a Drug Metabolising Organ
111. Percutaneous Delivery of Proteins and Peptides Using lontophoretic Techniques
112. Percutaneous Absorption of Benzoic Acid Across Human Skin: I. In vitro Experiments and Mathematical Modelling
113. Transport Mechanisms in Iontophoresis: I. A Theoretical Model for the Effect of Electroosmotic Flow in Flux Enhancement in Transdermal lontophoresis
114. The Role of Electroosmotic Flow in Transdermal Iontophoresis
115. Transport Mechanisms in Iontophoresis: II. Electroosmotic Flow and Transfer Number Measurements for Hairless Mouse Skin
116. Transport Mechanisms in Iontophoresis: III. An Experimental Study of the Contributions of Electroosmotic Flow and Permeability Change in Transport of Low and High Molecular Weight Solutes
117. Predicting Skin Permeability
118. Routes of Ionic Permeability Through Mammalian Skin
119. Tissue Electroporation: Observation of Reversible Electrical Breakdown in Viable Frog Skin
120. Transdermal Drug Delivery by Electroporation
121. Electroporation of Mammalian Skin: A Mechanism to Enhance Transdermal Drug Delivery
122. Drug Delivery Systems: 6. Transdermal Drug Delivexy
123. Surfactant Structure Effects on Swelling of Isolated Human Stratum Corneum
124. Transdermal Permeability and Skin Accumulation of Amino Acids
125. Antibodies for Treating and Preventing Disease: The Potential Role of Polymeric Controlled Release
126. Lontophoretic Delivery of Nonpeptide Drugs: Formulation Optimization for Maximum Skin Permeability
127. Use of Polymeric Buffers to Facilitate Jontophoretic Transport of Drugs
128. Mechanism of Percutaneous Absorption: I. Routes of Penetration and the Influence of Solubility
129. Mechanism of Percutaneous Absorption: II. Transient Diffusion and the Relative Importance of Various Routes of Skin Penetration
130. Permeability of the Skin
131. Effects of Ionic Surfactants on the Permeability of the Human Epidermis: An Electrometric Study
132. Effects of Surfactants and Solvents on the Permeability of Epidermis
133. Transport of Ionic Species in Skin: Contribution of Pores to the Overall Skin Conductance
134. Insulin Iontophoresis in Cystic Fibrosis
135. Percutaneous Absorption of Electron‐Dense Ions Across Normal and Chemically Perturbed Skin
136. Use of Theoretical Partition Coefficients Determined from Solubility Parameters to Predict Permeability Coefficients for 5‐Fluorouracil
137. Facilitated Transdermal Transport of Insulin
138. Baseline Studies on lontophoretic Transport in Hairless Mouse Skin: The Effect of Applied Voltage Drop and pH on the lontophoresis of a Model Weak Electrolyte
139. Phonophoresis
140. Prodrugs for Dermal Delivery
141. Mechanisms of Electroporation and Electrofusion
142. Transdermal lontophoretic Drug Delivery: Mechanistic Analysis and Application to Polypeptide Delivery
143. Lontophoresis of Polypeptides: Effect of Ethanol Pretreatment of Human Skin
144. Potential Novel Methods for Insulin Administration: I. Iontophoresis
145. Enhanced Percutaneous Penetration with 1‐Dodecyl‐azacycloheptan‐2‐one
146. Azone: A New Non‐Toxic Enhancer of Cutaneous Penetration
147. Transdermal Delivery of Insulin to Alloxan‐Diabetic Rabbits by Ultrasound Exposure
148. Transdermal Delivery of Insulin by Ultrasonic Vibration
149. Effect of Electroporation of the Iontophoretic Delivery of Peptides in vitro
150. Drug Metabolism in the Skin: Advantages and Disadvantages
151. Human Calcitonin in Rats by lontophoresis
152. In Vivo Electroporation and Stable Transformation of Skin Cells of Newborn Mice by Plasmid DNA
153. Mathematical Model of lontophoretic Transdermal Drug Delivery
154. Random Brick Model for Drug Transport across Stratum Corneum
155. Lontophoresis of Poly‐L‐lysines: Transport as a Function of Molecular Weight Measured by Confocal Microscopy
156. Drug Delivery by Phonophoresis
157. Azone
158. Effect of Stratum Comeum Hydration. How Serious Is It?
159. Thermal Analysis of Human Stratum Corneum
160. Stand and Deliver: Getting Peptide Drugs into the Body
161. Penetration Enhancers and Their Use in Transdermal Therapeutic Systems
162. Recent Progress in Protein and Peptide Delivery by Noninvasive Routes
163. Iontophoresis‐Facilitated Transdermal Delivery of Verapamil. I. In vitro Evaluation and Mechanistic Studies
164. A Numerical Approach to Study the Effect of Binding on the lontophoretic Transport of a Series of Amino Acids
165. Progress Toward a Theoretical Model for Electroporation Mechanism: Membrane Electrical Behavior and Molecular Transport
166. Interactions of Dimethyl Sulfoxide with Lipid and Protein Monolayers
167. Stratum Corneum: Biological and Biochemical Considerations
168. Percutaneous Absorption of Azone Following Single and Multiple Doses to Human Volunteers
169. Transformation of Bacillus Brevis 47 by Electroporation
170. Model Describing Transdermal lontophoretic Delivery of Lidocaine Incorporating Consideration of Microvascular State
171. The Effect of Various Detergents on Human Epidermis
172. Vehicle Effect on Topical Drug Delivery: III. Effect of Azone on the Cutaneous Permeation of Metronidazole and Propylene Glycol
173. Structure‐Transport Relationships in Transdermal lontophoresis
174. Solute Molecular Size and Transdernial lontophoresis across Excised Human Skin